Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
Annales De Biologie Clinique|January 1, 1986
[Dyslipidemias and coronary disease]P Douste-Blazy, L Douste-BlazyAnnales De Cardiologie Et D'Angeiologie|September 1, 1991
[Regression of a coronary atheroma. Proof and doubts]J Ferrières, P Douste-Blazy, P BernadetLa Revue Du Praticien|April 20, 1989
[Cholesterol: from where does it come, how does it circulate, where does it go?]G Luc, P Douste-Blazy, J C FruchartLa Revue Du Praticien|April 20, 1989
[Regulation of blood cholesterol, mechanism of hypercholesterolemia]G Luc, P Douste-Blazy, J C FruchartChemistry and Physics of Lipids|December 1, 1984
Fluorescence quenching by iodide ions of low density lipoproteins from normolipidemic and hypercholesterolemic type IIa subjects. Effect of low density lipoprotein-cholesterol and low density lipoprotein non-apolipoprotein-BQ Q Dang, P Douste-Blazy, R Camare, et al.The Journal of Clinical Investigation|July 1, 1981
Characterization of monoclonal antibodies against human apolipoprotein ER W Milne, P Douste-Blazy, Y L Marcel, et al.Metabolism: Clinical and Experimental|March 1, 1990
Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein compositionJ M Bard, H J Parra, P Douste-Blazy, et al.Thrombosis and Haemostasis|December 29, 1984
Exercise-induced platelet activation in myocardial infarction survivors with normal coronary arteriogramP Douste-Blazy, P Sié, B Boneu, et al.Annals of Internal Medicine|February 1, 1982
Increased Frequency of Apo E-ND phenotype and hyperapobeta-lipoproteinemia in normolipidemic subjects with xanthelasmas of the eyelidsP Douste-Blazy, Y L Marcel, L Cohen, et al.Pageof 5